Seventy years of evidence on the efficacy and safety of drugs for treating leprosy: a network meta-analysis - 01/04/23
, Jingjing Chen a, Meixiao Liu a, Yuxin Fan a, Li Peng a, Jieqin Song a, Xinya Wu a, Li Gao a, Weijiang Ma a, Yan Dong a, Suyi Luo a, Fukai Bao a, b, ⁎ Summary |
Objective |
The World Health Organization (WHO) recommends multidrug therapy (MDT) with rifampicin, dapsone, and clofazimine for treating leprosy, which is based on very low-quality evidence. Here, we performed a network meta-analysis (NMA) to produce quantitative evidence to strengthen current WHO recommendations.
Method |
All studies were obtained from Embase and PubMed from the date of establishment to October 9, 2021.
Data were synthesized with frequentist random-effects network meta-analyses. Outcomes were assessed using odds ratios (ORs), 95% confidence intervals (95% CIs), and P score.
Results |
Sixty controlled clinical trials and 9256 patients were included. MDT was effective (range of OR: 1.06–1255584.25) for treating leprosy and multibacillary leprosy. Six treatments (Range of OR: 1.199–4.50) were more effective than MDT. Clofazimine (P score=0.9141) and dapsone+rifampicin (P score=0.8785) were effective for treating type 2 leprosy reaction. There were no significant differences in the safety of any of the tested drug regimens.
Conclusions |
The WHO MDT is effective for treating leprosy and multibacillary leprosy, but it may not be effective enough. Pefloxacin and ofloxacin may be good adjunct drugs for increasing MDT efficacy. Clofazimine and dapsone+rifampicin can be used in the treatment of a type 2 leprosy reaction. Single-drug regimens are not efficient enough to treat leprosy, multibacillary leprosy, or a type 2 leprosy reaction.
Availability of data and materials |
All data generated or analyzed during this study are included in this published article [and its Appendix A files].
Le texte complet de cet article est disponible en PDF.Highlights |
• | WHO multidrug therapy (MDT) is still the mainstay for leprosy treatment. |
• | Pefloxacin, ofloxacin, acedapsone, and prednisolone may augment efficacy of MDT. |
• | Most single-drug regimens were less effective than multidrug regimens. |
• | Difference of safety has not been observed among drugs for treating leprosy. |
Keywords : Mycobacterium leprae, Leprosy, Antibiotic treatment, Efficacy, Safety, Network meta-analysis
Plan
Vol 86 - N° 4
P. 338-351 - avril 2023 Retour au numéro
Article précédent
- The oropharynx of men using HIV pre-exposure prophylaxis is enriched with antibiotic resistance genes: A cross-sectional observational metagenomic study
- Christophe Van Dijck, Jolein Gyonne Elise Laumen, Tessa de Block, Saïd Abdellati, Irith De Baetselier, Achilleas Tsoumanis, Surbhi Malhotra-Kumar, Sheeba Santhini Manoharan-Basil, Chris Kenyon, Basil Britto Xavier
- Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study
- Andrew Evans, Cathy Qi, Jubril Omololu Adebayo, Jonathan Underwood, James Coulson, Rowena Bailey, Ronan Lyons, Adrian Edwards, Alison Cooper, Gareth John, Ashley Akbari
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?